NEXTNRG, INC. Files 8-K on New Agreement and Equity Sales

Ticker: NXXT · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1817004

Sentiment: neutral

Topics: material-definitive-agreement, unregistered-sales-of-equity-securities

TL;DR

NEXTNRG signed a deal and sold stock, details to follow.

AI Summary

On October 9, 2025, NEXTNRG, INC. filed an 8-K report detailing two key events: entering into a material definitive agreement and reporting unregistered sales of equity securities. The filing does not provide specific details on the nature of the agreement or the terms of the equity sales.

Why It Matters

This filing indicates NEXTNRG, INC. has entered into a significant new contract and has issued new equity, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The filing indicates new agreements and equity sales, which can introduce financial and operational risks if not managed effectively.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by NEXTNRG, INC.?

The filing does not specify the details of the material definitive agreement.

When was the material definitive agreement entered into?

The filing indicates the report date is October 9, 2025, suggesting the agreement was entered into on or before this date.

What type of equity securities were sold by NEXTNRG, INC.?

The filing mentions unregistered sales of equity securities but does not specify the type.

Were the unregistered equity sales registered with the SEC?

The filing explicitly states 'Unregistered Sales of Equity Securities', indicating they were not registered.

What is NEXTNRG, INC.'s principal executive office address?

NEXTNRG, INC.'s principal executive offices are located at 67 NW 183rd Street, Miami, Florida 33169.

Filing Stats: 1,191 words · 5 min read · ~4 pages · Grade level 15.3 · Accepted 2025-10-09 16:30:47

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 9, 2025 NEXTNRG, INC. (Exact name of registrant as specified in its charter) Delaware 001-40809 84-4260623 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 67 NW 183rd Street , Miami , Florida 33169 (Address of principal executive offices, including Zip Code) (305) 791-1169 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share NXXT Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01 Entry into Material Definitive Agreement As previously disclosed, on September 8, 2025, NextNRG, Inc. (the "Company") entered into securities purchase agreement (the "Purchase Agreement"), with an accredited investor (the "Investor"). Pursuant to the Purchase Agreement, the Company agreed to sell, and the Investor agreed to purchase (i) senior secured convertible notes of the Company, in the aggregate original principal amount of up to $11,800,000 (the "Notes"), which are convertible into shares of common stock, par value $0.0001 per share, of the Company ("Common Stock"), and (ii) warrants to purchase up to 3,000,000 shares of Common Stock, with an exercise price of $5.00 (the "Warrants). In connection with the transaction contemplated in the Purchase Agreement, the Company also agreed to issue to another accredited investor, who is a consultant of the Investor, due diligence notes, in the aggregate original principal amount of up to $1,180,000 (the "Due Diligence Notes") and due diligence warrants to purchase up to 300,000 shares of Common Stock, subject to adjustment as provided in the due diligence warrants (the "Due Diligence Warrants"). The initial closing was on September 8, 2025, where the Company issued Notes in the aggregate principal amount of $2,950,000, Warrants to purchase up to 750,000 shares of Common Stock, Due Diligence Notes in the aggregate principal amount of $295,000 and Due Diligence Warrants to purchase up to 75,000 shares of Common Stock (the "Initial Closing").The Company received $2,500,000 gross proceeds at the Initial Closing, which reflects an original issue discount of 18% on the Notes. Pursuant to the Purchase Agreement, on October 3, 2025, the Company and the Investor consummated an additional closing and the Company issued Notes in the aggregate principal amount of $1,475,000, Warrants to purchase up to 375,000 shares of Common Stock, Due Diligence Notes in the aggregate principal amount of $147,500 and Due Diligence Warrants to purchase up to 37,500 shares of Common Stock (the "Second Closing"). The Company received $1,250,000 gross proceeds at the Second Closing, which reflects an original issue discount of 18% on the Notes. Other than the amounts of the Notes, Warrants, Due diligence Notes and Due Diligence Warrants issued in the Second Closing, and the initial Conversion Price of the Notes and the Due Diligence Notes issued by the Company at the Second Closing, which is $1.92 per share of Common Stock, all other terms of the Notes, Warrants, Due diligence Notes and Due Diligence Warrants issued by the Company at the Second Closing are the same as the Notes, Warrants, Due diligence Notes and Due Diligence Warrants issued by the Company at the Initial Closing. The issuance of the shares of Common Stock issuable by the Company upon the conversion of the Notes or the Due Diligence Notes or upon the exercise of the Warrants or the Due Diligence Warrants that were issued at t

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing